Instil Bio Files 8-K

Ticker: TIL · Form: 8-K · Filed: Aug 15, 2024 · CIK: 1789769

Instil Bio, INC. 8-K Filing Summary
FieldDetail
CompanyInstil Bio, INC. (TIL)
Form Type8-K
Filed DateAug 15, 2024
Risk Levelmedium
Pages2
Reading Time2 min
Key Dollar Amounts$0.000001
Sentimentneutral

Sentiment: neutral

Topics: 8-K, regulatory-disclosure, financial-exhibits

TL;DR

Instil Bio dropped an 8-K, likely with news. Check it out.

AI Summary

Instil Bio, Inc. filed an 8-K on August 15, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific details about the nature of the disclosure or financial information within the provided text.

Why It Matters

This filing indicates Instil Bio is making a regulatory disclosure and submitting financial exhibits, which could contain important updates for investors.

Risk Assessment

Risk Level: medium — The filing is an 8-K, which often contains material information, but the specific content is not detailed here, necessitating further review.

Key Numbers

Key Players & Entities

FAQ

What specific information is being disclosed under Regulation FD?

The provided text of the 8-K filing does not specify the details of the Regulation FD disclosure.

What are the key financial statements or exhibits being filed?

The filing indicates that Financial Statements and Exhibits are being submitted, but their specific content is not detailed in the provided text.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on August 15, 2024.

What is Instil Bio, Inc.'s principal executive office address?

Instil Bio, Inc.'s principal executive office is located at 3963 Maple Avenue, Suite 350, Dallas, Texas 75219.

What is the SIC code for Instil Bio, Inc.?

The Standard Industrial Classification (SIC) code for Instil Bio, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).

Filing Stats: 539 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-08-15 17:00:13

Key Financial Figures

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure Instil Bio, Inc. (the "Company") from time to time presents and/or distributes to the investment community presentations related to its business. A copy of its most recent presentation is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit 99.1. The information herein and in the exhibit hereto is being furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 SYN-2510 Program Overview 104 the cover page of this report has been formatted in Inline XBRL.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Instil Bio, Inc. Dated: August 15, 2024 By: /s/ Sandeep Laumas, M.D. Sandeep Laumas, M.D. Chief Financial Officer and Chief Business Officer (Principal Financial Officer and Principal Accounting Officer)

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing